9-July-2019: The global hemodialysis
vascular grafts market size is expected to reach USD
276.5 million by 2025, according to a new report by Grand View Research, Inc.,
progressing at a CAGR of 4.1% during the forecast period. Increasing number of
patients suffering from chronic kidney diseases (CKD) and growing adoption of
biological access products due to technological advancements in the field are
some of the factors contributing to revenue growth. Higher number of renal
impaired patients and limited availability of suitable kidney donors are
promoting hemodialysis procedures in renal impaired patients, which in turn is
expected to fuel the demand for vascular grafts over the forecast period.
The global
hemodialysis vascular graft market, by raw material, was dominated by PTFE
grafts with a revenue share of 45.0% in 2018. The segment is anticipated to
maintain its position throughout the forecast period. High product penetration,
wide availability, and comparatively cheaper products are supplementing the
dominance of the segment. Moreover, recent development of biological grafts for
hemodialysis is expected to increase its adoption, owing to lower possibility
of rejection and infection of these products.
North America
dominated the market in 2018 and accounted for approximately 32.0% of the
overall revenue. The U.S. is a key revenue contributor not only in the region
but at the global marketplace as well. The growth of the market in the country
can be attributed to growing number of renal impaired patients undergoing hemodialysis
and surging demand for AVGs required to create superficial access for blood
transfusion.
Developing
economies such as China and India have lower availability of kidney donors as
compared to developed economies. Thus patients opt for alternatives such as
hemodialysis. Increase in number of hemodialysis procedures is expected to
drive the market between 2018 and 2025. Asia Pacific is poised to exhibit a
CAGR of 6.6% between 2018 and 2025, owing to increasing number of patients with
CKD, growing awareness regarding safety of AVG, and rising healthcare
expenditure.
In
depth research report on Hemodialysis Vascular Grafts Market
Further Key Findings From the Report Suggest:
·
North America dominated the market in 2017, owing to
geightened awareness regarding treatment options available, increasing adoption
of hemodialysis access grafts, and technological advancements in AVG
·
Asia Pacific is anticipated to be the fastest growing
regional hemodialysis vascular graft market with a CAGR of 6.6 % between 2018
and 2025
·
Some of the key market players in this market are W.L. Gore
& Associates; C. R. Bard, Inc.; Terumo Medical Corporation; LeMaitre
Vascular, Inc.; Getinge AB; Vascular Genesis; InnAVasc Medical, Inc.; CryoLife,
Inc.; Merit Medical Systems, Inc.; and Proteon Therapeutics, Inc.
Grand View Research
has segmented the global hemodialysis vascular graft market on the basis of raw
material types, and region:
Hemodialysis Vascular Grafts Raw Material Outlook (Revenue,
USD Million, 2014 - 2025)
·
Polyester
·
Polytetrafluoroethylene
·
Polyurethane
·
Biological Materials
Browse
more research reports of this category:
About
Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
No comments:
Post a Comment